These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 23506246)
21. Sustained release of lidocaine from Poloxamer 407 gels. Ricci EJ; Lunardi LO; Nanclares DM; Marchetti JM Int J Pharm; 2005 Jan; 288(2):235-44. PubMed ID: 15620863 [TBL] [Abstract][Full Text] [Related]
22. Preformulation and characterization of a lidocaine hydrochloride and dexamethasone sodium phosphate thermo-reversible and bioadhesive long-acting gel for intraperitoneal administration. Arbelaez-Camargo D; Suñé-Negre JM; Roig-Carreras M; García-Montoya E; Pérez-Lozano P; Miñarro-Carmona M; Ticó-Grau JR Int J Pharm; 2016 Feb; 498(1-2):142-52. PubMed ID: 26685726 [TBL] [Abstract][Full Text] [Related]
23. Injectable thermosensitive gelling delivery system for the sustained release of lidocaine. Svirskis D; Chandramouli K; Bhusal P; Wu Z; Alphonso J; Chow J; Patel D; Ramakrishna R; Yeo SJ; Stowers R; Hill A; Munro J; Young SW; Sharma M Ther Deliv; 2016 Jun; 7(6):359-68. PubMed ID: 27250538 [TBL] [Abstract][Full Text] [Related]
24. In-vivo anti-tumor activity of a novel poloxamer-based thermosensitive in situ gel for sustained delivery of norcantharidin. Xie MH; Ge M; Peng JB; Jiang XR; Wang DS; Ji LQ; Ying Y; Wang Z Pharm Dev Technol; 2019 Jun; 24(5):623-629. PubMed ID: 30457414 [TBL] [Abstract][Full Text] [Related]
25. Sustained delivery of IL-1Ra from PF127-gel reduces hyperglycemia in diabetic GK-rats. Akash MS; Rehman K; Sun H; Chen S PLoS One; 2013; 8(2):e55925. PubMed ID: 23409091 [TBL] [Abstract][Full Text] [Related]
27. Enhancing thermal stability of a highly concentrated insulin formulation with Pluronic F-127 for long-term use in microfabricated implantable devices. Li J; Chu MK; Lu B; Mirzaie S; Chen K; Gordijo CR; Plettenburg O; Giacca A; Wu XY Drug Deliv Transl Res; 2017 Aug; 7(4):529-543. PubMed ID: 28429276 [TBL] [Abstract][Full Text] [Related]
28. Sustained release of 5-FU from Poloxamer gels interpenetrated by crosslinking chitosan network. Chung TW; Lin SY; Liu DZ; Tyan YC; Yang JS Int J Pharm; 2009 Dec; 382(1-2):39-44. PubMed ID: 19666095 [TBL] [Abstract][Full Text] [Related]
29. Investigation on solution-to-gel characteristic of thermosensitive and mucoadhesive biopolymers for the development of moxifloxacin-loaded sustained release periodontal in situ gels. Sheshala R; Quah SY; Tan GC; Meka VS; Jnanendrappa N; Sahu PS Drug Deliv Transl Res; 2019 Apr; 9(2):434-443. PubMed ID: 29392681 [TBL] [Abstract][Full Text] [Related]
30. PLGA:poloxamer blend micro- and nanoparticles as controlled release systems for synthetic proangiogenic factors. Parajó Y; d'Angelo I; Horváth A; Vantus T; György K; Welle A; Garcia-Fuentes M; Alonso MJ Eur J Pharm Sci; 2010 Dec; 41(5):644-9. PubMed ID: 20869438 [TBL] [Abstract][Full Text] [Related]
31. [Preparation and properties of thermosensitive in situ gel for ophthalmic formulation containing pearl hydrolyzate]. Song LN; Li HR; Wang HY; Li Z; Zhao WC; Lu FZ; Li SM Yao Xue Xue Bao; 2016 Oct; 51(10):1622-8. PubMed ID: 29932618 [TBL] [Abstract][Full Text] [Related]
32. Formulation and preliminary in vivo dog studies of a novel drug delivery system for the treatment of periodontitis. Kelly HM; Deasy PB; Ziaka E; Claffey N Int J Pharm; 2004 Apr; 274(1-2):167-83. PubMed ID: 15072793 [TBL] [Abstract][Full Text] [Related]
33. A novel poloxamers/hyaluronic acid in situ forming hydrogel for drug delivery: rheological, mucoadhesive and in vitro release properties. Mayol L; Quaglia F; Borzacchiello A; Ambrosio L; La Rotonda MI Eur J Pharm Biopharm; 2008 Sep; 70(1):199-206. PubMed ID: 18644705 [TBL] [Abstract][Full Text] [Related]
34. Stimuli-Responsive in situ Spray Gel of Miconazole Nitrate for Vaginal Candidiasis. Hsin YK; Thangarajoo T; Choudhury H; Pandey M; Meng LW; Gorain B J Pharm Sci; 2023 Feb; 112(2):562-572. PubMed ID: 36096286 [TBL] [Abstract][Full Text] [Related]
35. In vitro characterization of a formulation of butorphanol tartrate in a poloxamer 407 base intended for use as a parenterally administered slow-release analgesic agent. Laniesse D; Smith DA; Knych HK; Mosley C; Guzman DS; Beaufrère H Am J Vet Res; 2017 Jun; 78(6):677-687. PubMed ID: 28541144 [TBL] [Abstract][Full Text] [Related]
36. Chitosan in situ gelation for improved drug loading and retention in poloxamer 407 gels. Ur-Rehman T; Tavelin S; Gröbner G Int J Pharm; 2011 May; 409(1-2):19-29. PubMed ID: 21335076 [TBL] [Abstract][Full Text] [Related]
37. Rheological characterization and in vivo evaluation of thermosensitive poloxamer-based hydrogel for intramuscular injection of piroxicam. Xuan JJ; Balakrishnan P; Oh DH; Yeo WH; Park SM; Yong CS; Choi HG Int J Pharm; 2010 Aug; 395(1-2):317-23. PubMed ID: 20573569 [TBL] [Abstract][Full Text] [Related]
38. Controlled release ibuprofen-poloxamer gel for epidural use - A pharmacokinetic study using microdialysis in pigs. Paavola A; Bernards CM; Rosenberg PH Eur J Pharm Biopharm; 2016 Nov; 108():180-186. PubMed ID: 27615997 [TBL] [Abstract][Full Text] [Related]